The chart solidifies you what you already know: Biotech stocks are off to a blistering start in 2014.
The iShares Nasdaq Biotechnology Index ETF (IBB) is trouncing the S&P 500 through the first three weeks of the year.
IBB data by YCharts
It's hard to imagine, but biotech stocks are starting off 2014 stronger than they did in 2013.
Here's the same IBB vs. S&P 500 comparison as above, but looking at the first 20 calendar days of 2013:
The top-performing biotech and drug stocks year to date, according to S&P CapitalIQ:
Intercept Pharma (ICPT - Get Report) +329%
Rexahn Pharma (RNN)+116%
Neurocine Biosciences (NBIX - Get Report) +110%
CorMedix (CRMD - Get Report) +98%
Cell Therapeutics (CTIC - Get Report) +91%
05/19/15 - 04:42 PM EDT
05/19/15 - 12:48 PM EDT
05/18/15 - 08:06 AM EDT
05/05/15 - 02:43 PM EDT
05/05/15 - 10:40 AM EDT
09/02/15 - 08:59 AM EDT
09/01/15 - 08:32 AM EDT
08/31/15 - 01:03 AM EDT
08/31/15 - 01:01 AM EDT
08/31/15 - 01:00 AM EDT
Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.